LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | AZD8055 | 10 | uM | LJP6 | 2 | A07 | 72 | hr | 765 | 486 | 3095 | 0.1570 | -0.2015 |
Hs 578T | AZD8055 | 10 | uM | LJP6 | 3 | A07 | 72 | hr | 765 | 660 | 3066 | 0.2153 | -0.0711 |
Hs 578T | Sorafenib | 0.04 | uM | LJP6 | 1 | B12 | 72 | hr | 765 | 3637 | 3143 | 1.1569 | 1.1482 |
Hs 578T | Sorafenib | 0.04 | uM | LJP6 | 2 | B12 | 72 | hr | 765 | 3630 | 3095 | 1.1726 | 1.1643 |
Hs 578T | Sorafenib | 0.04 | uM | LJP6 | 3 | B12 | 72 | hr | 765 | 3521 | 3066 | 1.1484 | 1.1431 |
Hs 578T | Sorafenib | 0.12 | uM | LJP6 | 1 | B11 | 72 | hr | 765 | 3654 | 3143 | 1.1623 | 1.1531 |
Hs 578T | Sorafenib | 0.12 | uM | LJP6 | 2 | B11 | 72 | hr | 765 | 3615 | 3095 | 1.1678 | 1.1599 |
Hs 578T | Sorafenib | 0.12 | uM | LJP6 | 3 | B11 | 72 | hr | 765 | 3492 | 3066 | 1.1389 | 1.1342 |
Hs 578T | Sorafenib | 0.37 | uM | LJP6 | 1 | B10 | 72 | hr | 765 | 3730 | 3143 | 1.1865 | 1.1750 |
Hs 578T | Sorafenib | 0.37 | uM | LJP6 | 2 | B10 | 72 | hr | 765 | 3724 | 3095 | 1.2030 | 1.1919 |
Hs 578T | Sorafenib | 0.37 | uM | LJP6 | 3 | B10 | 72 | hr | 765 | 3850 | 3066 | 1.2557 | 1.2408 |
Hs 578T | Sorafenib | 1.11 | uM | LJP6 | 1 | B09 | 72 | hr | 765 | 3786 | 3143 | 1.2043 | 1.1909 |
Hs 578T | Sorafenib | 1.11 | uM | LJP6 | 2 | B09 | 72 | hr | 765 | 3882 | 3095 | 1.2540 | 1.2376 |
Hs 578T | Sorafenib | 1.11 | uM | LJP6 | 3 | B09 | 72 | hr | 765 | 3821 | 3066 | 1.2462 | 1.2324 |
Hs 578T | Sorafenib | 3.33 | uM | LJP6 | 1 | B08 | 72 | hr | 765 | 3824 | 3143 | 1.2164 | 1.2017 |
Hs 578T | Sorafenib | 3.33 | uM | LJP6 | 2 | B08 | 72 | hr | 765 | 3789 | 3095 | 1.2240 | 1.2108 |
Hs 578T | Sorafenib | 3.33 | uM | LJP6 | 3 | B08 | 72 | hr | 765 | 3697 | 3066 | 1.2058 | 1.1959 |
Hs 578T | Sorafenib | 10 | uM | LJP6 | 1 | B07 | 72 | hr | 765 | 2830 | 3143 | 0.9002 | 0.8995 |
Hs 578T | Sorafenib | 10 | uM | LJP6 | 2 | B07 | 72 | hr | 765 | 3027 | 3095 | 0.9778 | 0.9779 |
Hs 578T | Sorafenib | 10 | uM | LJP6 | 3 | B07 | 72 | hr | 765 | 2707 | 3066 | 0.8829 | 0.8794 |
Hs 578T | CP466722 | 0.04 | uM | LJP5 | 1 | I12 | 72 | hr | 765 | 3160 | 3140 | 1.0063 | 1.0061 |
Hs 578T | CP466722 | 0.04 | uM | LJP5 | 2 | I12 | 72 | hr | 765 | 3318 | 3151 | 1.0528 | 1.0510 |
Hs 578T | CP466722 | 0.04 | uM | LJP5 | 3 | I12 | 72 | hr | 765 | 3230 | 3152 | 1.0246 | 1.0239 |
Hs 578T | CP466722 | 0.12 | uM | LJP5 | 1 | I11 | 72 | hr | 765 | 3263 | 3140 | 1.0391 | 1.0380 |
Hs 578T | CP466722 | 0.12 | uM | LJP5 | 2 | I11 | 72 | hr | 765 | 3184 | 3151 | 1.0103 | 1.0100 |